Additionally, glucose hypometabolism, which is associated with reductions in cerebrovascular GLUT1 expression, can predict cognitive decline in normal aging subjects and progression of Alzheimer’s disease (AD)20–30. This evidence concerns the gene SLC2A1 and Alzheimer disease.